Streetbeat News

Products Services

BGNE

BeiGene (NASDAQ:BGNE) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending approval for tislelizumab as a treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:58 am

META

Meta Platforms Inc's Instagram-linked app Threads is facing a user exodus, with daily active users dropping to 23.6 million from a peak of 49 million in July. The company is focusing on improving performance and introducing new features rather than increasing user engagement. Threads' relationship with Instagram initially boosted its popularity, but users were disappointed by the required Instagram account deletion to ditch Threads. Meta's shares are trading higher by 0.19% at $303.10 premarket on the last check Friday.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 11:58 am

MRK

Merck (NYSE:MRK) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for gefapixant, a non-narcotic oral selective P2X3 receptor antagonist developed for the treatment of adults with chronic cough. The recommendation will be reviewed by the European Commission for marketing authorization in the EU, with a final decision expected later this year.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:53 am

PFE

VGK

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Pfizer's Litfulo (Ritlecitinib) for the treatment of severe alopecia areata.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:52 am

META

According to the Wall Street Journal, user engagement on Meta's Threads has fallen to 13 million, a 70% decrease from its peak on July 7.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:43 am

AAPL

Apple Inc's upcoming iPhone 15 Pro and Pro Max models are facing manufacturing issues, potentially delaying their debut and impacting Apple's profit margins. The screens made by LG Display have failed reliability tests, causing delays and shortages. Bank of America analyst Wamsi Mohan warns of potential delays in the iPhone 15's debut, projecting Apple's fourth-quarter revenue to be $87.1 billion, falling short of the consensus estimate of $91.6 billion due to the possible delay.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 11:42 am

BRTX

BioRestorative Therapies has received a license from the New York State Department of Health to operate as a tissue bank. This license allows the company to process mesenchymal stem cells obtained from autologous donors.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:14 am

AAPL

Apple Inc. (NASDAQ:AAPL) has launched a new website interface to streamline the buying experience for Apple Watches. The new interface includes detailed images and descriptions of different Apple Watch models and bands. Apple is rumored to launch the Apple Watch Series 9 and Apple Watch Ultra 2 in September, with key features including non-invasive blood glucose monitoring.

Portfolio Pulse from Rounak Jain

July 21, 2023 | 11:08 am

BMY

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approval of Bristol Myers Squibb's Opdivo (Nivolumab) as a monotherapy for the adjuvant treatment of adults and adolescents with completely resected stage IIB or IIA melanoma.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:02 am

BTCUSD

COIN

ETHUSD

Coinbase has announced that it will fully shut down its Borrow Lending Program in November. This comes after the company faced regulatory scrutiny from the SEC over the program.

Portfolio Pulse from Charles Gross

July 21, 2023 | 10:33 am